Blog sidebar

ALGOGram™ Spring session is coming. Register now! 🌺

ALGOGram™, your decision making guide!
The registration for the upcoming ALGOGram™ session is now open!
Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas:
Acute & tonic pain
Inflammatory pain
Neuropathic pain
Postoperative pain
Visceral pain

ALGOGram™ Winter session is coming. Register now! ❄️

ALGOGram™, your decision making guide!
The registration for the upcoming ALGOGram™ session is now open!
Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas:
Acute & tonic pain
Inflammatory pain
Neuropathic pain
Postoperative pain
Visceral pain

SfN 2023: Meet with ANS Biotech!

This year, Neuroscience will be held in-person in Washington, DC, November 12-15.
Each year, SfN offers to scientists from around the world to congregate and discover new ideas, share their research, and experience the best the field has to offer.
We at ANS Biotech are thrilled to announce our participation in the upcoming SfN 2023.
It’s an exciting opportunity for us to connect with industry peers and to share insights in the field of preclinical pharmacology of pain.
We extend a warm invitation for you to join us on this remarkable event in Neuroscience! 

ALGOGram™ Fall session is coming. Register now! 🍁

ALGOGram™, your decision making guide!
The registration for the upcoming ALGOGram™ session is now open!
Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas:
Acute & tonic pain
Inflammatory pain
Neuropathic pain
Postoperative pain
Visceral pain
Assays seamlessly orchestrated during a 3 week experimental phase!

📅 From 10 November to 01 December

ALGOGram™ Back to school session is coming. Register now! 🎒

ALGOGram™, your decision making guide!
The registration for the upcoming ALGOGram™ session is now open!
Assays seamlessly orchestrated during a 3 week experimental phase!

📅 From 22 September to 13 October
Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas:
Acute & tonic pain
Inflammatory pain
Neuropathic pain
Postoperative pain
Visceral pain

AAV Testing available at ANS Biotech

We are proud to announce that we have obtained a 5-year approval from the French Ministry of Education and Research to use genetically modified organisms of containment class 1.
Gene therapy with adeno-associated virus (AAV) has advanced in the last few years from promising results in animal models to >100 clinical trials.
We have now the possibility to assess the efficacy of your gene therapy in our facilities.
Should you want to test your AAV in our pain models do not hesitate to contact us.

ALGOGram™ Spring session is coming . Register now! 🌺

ALGOGram™, your decision making guide! The registration for the upcoming ALGOGram™ session is now open! Assays seamlessly orchestrated during a 3 week experimental phase! 📅 From 17 March to 07 April Explore the activity of your compounds in 10 fully validated pain models / tests across 5 different pain areas: Acute & tonic pain Inflammatory pain [...]

Poster #128.08, SFN Congress 2022

Tactile and mechanical allodynia are symptoms experienced by many patients suffering from different pathology especially from neuropathy.  In patients with post-traumatic / postsurgical neuropathic pain, different methods were performed to evaluate tactile and mechanical allodynia. In rat, different models such as Chronic Constriction Injury (CCI) and Spared Nerve Injury (SNI) mimic neuropathic pain symptoms.  The [...]

Poster #PTU-12, IASP Congress 2022

Oxaliplatin is a third-generation platinum-based chemotherapy drug widely used in the treatment of advanced metastatic colorectal cancer. Its use is limited by a cumulative and chronic neurotoxicity, characterized by dysesthesia and paresthesia in the distal extremities, spontaneous pain and loss of sensation. In nonhuman animals, oxaliplatin treatment produces significant behavioural nociceptive signs (cold allodynia), consistent [...]

A model of Morphine-induced Tolerance in rats is now available

Opioid crisis: a social and economic issue From the observation... Pain is a major social issue requiring the continuous development of new analgesics. With a lack of effective and safe non opioid options for pain management, the use of drugs with opioid based mechanisms of action remains current and associated with numerous adverse effects, including [...]